Article
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived.
Current oncology reports - 14 Mar 2020
Milne Kate, Sturrock Beattie, Chevassut Timothy
Abstract excerpt
PURPOSE OF REVIEW: Chronic lymphocytic leukaemia is now recognised as a heterogenous disease with a variety of clinical outcomes. Here we summarise the way it is currently stratified according to genetic risk and patient characteristics and the treatment approaches used for these different subgroups. RECENT FINDINGS: Certain patients appear to sustain MRD negativity after combination chemoimmunotherapy, leading...
Topics
Join the communities discussing this publication.
